Serial #79404163
LIVE

Serial Number

79404163

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

May 6, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79404163 Trademark

Serial Number: 79404163 • Registration: 8016754

Serial #79404163 is a trademark filed by NOVARTIS AG on May 6, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 6, 2024

Registration Date

November 11, 2025

Published for Opposition

September 23, 2025

Goods & Services

Medical apparatus and instruments for diagnosing and treating cardiovascular diseases; Medical apparatus and instruments for diagnosing and treating dermatological diseases; medical apparatus and instruments for diagnosing and treating respiratory diseases and disorders; medical apparatus and instruments for diagnosing and treating central nervous system diseases; medical apparatus and instruments for the diagnosis and treatment of gastro-intestinal diseases; medical apparatus and instruments for the diagnosis, prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; medical apparatus and instruments for the diagnosis, prevention and treatment of hematology diseases and disorders; medical apparatus and instruments for use in tissue and organ transplantation surgery; medical apparatus and instruments for the diagnosis, prevention and treatment of eye diseases and conditions; medical apparatus and instruments for the diagnosis, prevention and treatment of heart rhythm disorders; medical apparatus and instruments for the diagnosis, prevention and treatment of immune system related diseases and disorders.

Anti-infectives; Anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Providing information in the fields of medicine and health via a website; Providing information about the diagnostic, prophylactic and therapeutic properties of medicines via a website; providing information in the medical field and information in the field of diagnostic, prophylactic and therapeutic properties of medicines; providing health information; providing patients with information in the medical field.

Providing on-line journals, namely, blogs in the medical, pharmaceutical and health fields.

Medical and pharmaceutical research services; Pharmaceutical research and development.

Downloadable software for the facilitation of communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical and health fields; Downloadable software in the nature of a mobile application for facilitation of communication, namely, allowing patients and healthcare professionals to access and share information in the medical, pharmaceutical and health fields.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 11, 2026 FINV
FINAL DISPOSITION NOTICE SENT TO IB
May 25, 2026 FICS
FINAL DISPOSITION PROCESSED
May 25, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 26, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 11, 2026 OPNS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 11, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 11, 2026 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 11, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 11, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 23, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 23, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 17, 2025 NONP
REFUSAL PROCESSED BY IB
Aug 29, 2025 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 27, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 20, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 20, 2025 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 8, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 7, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 6, 2025 RFCR
NON-FINAL ACTION WRITTEN
Aug 5, 2025 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Nov 13, 2024 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 7, 2024 RFCR
NON-FINAL ACTION WRITTEN
Nov 6, 2024 CNRT
ASSIGNED TO EXAMINER
Nov 4, 2024 DOCK
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 11, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 11, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 11, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 11, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 11, 2024 COAR
APPLICATION FILING RECEIPT MAILED
Oct 7, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 7, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 19, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 12, 2024 REPR